We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SAP:TSXSaputo Inc. Analysis

Data as of 2026-03-14 - not real-time

CA$42.48

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Saputo’s shares are trading just above the 20‑day SMA and comfortably above the 50‑day SMA, indicating a short‑term bullish bias despite a bearish MACD histogram and a recent dip in trading volume. The price sits near a key support level around $41.70 and below a clear resistance near $43.60, suggesting limited upside unless the stock can break the resistance zone. Volatility over the past month is moderate at roughly 22%, while the beta of the stock is low, reflecting limited sensitivity to broader market moves. The consumer‑defensive sector provides a cushion in uncertain markets, and the company continues to pay a 1.86% dividend with a 50% payout ratio, supporting income‑focused investors. However, revenue has contracted by about 2% year‑over‑year, margins remain thin, and the DCF‑derived fair value of roughly $30 is well below the current market price, flagging an overvaluation risk. Recent material news disclosed the sale of an 80% stake in the Argentine dairy division, generating net proceeds that could strengthen the balance sheet but also reduces exposure to a volatile market. The transaction is expected to improve cash generation while leaving a 20% minority interest for future upside. Forward earnings estimates suggest a healthier EPS trajectory, yet the modest growth profile aligns more with a value‑oriented play than a high‑growth story. Overall, the stock’s defensive positioning and dividend yield are attractive, but the price premium and muted growth temper enthusiasm.
Investors should watch for a decisive move above the $43.60 resistance and any further shifts in volume or MACD momentum. A sustained break could unlock the modest upside implied by analyst targets, while a failure to clear resistance may keep the stock constrained near its current range. The Argentine divestiture, combined with a stable dividend and low beta, supports a cautious but not overly defensive stance for medium‑term holders.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD histogram and decreasing volume
  • Proximity to near‑term support level
  • Limited upside until resistance is broken

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Price above 20‑day SMA and bullish trend direction
  • Attractive dividend yield with sustainable payout
  • Forward earnings improvement and analyst price targets above current level

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Defensive consumer staples positioning
  • Stable dividend providing income cushion
  • Fundamental growth constraints and current price premium

Key Metrics & Analysis

Financial Health

Revenue Growth-2.10%
Profit Margin3.39%
P/E Ratio27.2
ROE9.41%
ROA5.11%
Debt/Equity52.51
P/B Ratio2.6
Op. Cash FlowCA$1.5B
Free Cash FlowCA$1.1B

Technical Analysis

TrendBullish
RSI50.7
SupportCA$41.71
ResistanceCA$43.60
MA 20CA$42.60
MA 50CA$41.93
MA 200CA$35.30
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88

Valuation

Fair ValueCA$30.05
Target PriceCA$44.64
Upside/Downside5.08%
GradeOvervalued
TypeValue
Dividend Yield1.86%

Risk Assessment

Beta0.32
Volatility22.15%
Sector RiskLow
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.